Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
NCT ID: NCT05377216
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
EARLY_PHASE1
20 participants
INTERVENTIONAL
2022-09-01
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia
NCT04770051
Ventricular Tachycardia Mechanisms
NCT05478213
TcMS to Treat Ventricular Tachycardia
NCT05016921
Postoperative Atrial Fibrillation Suppression By Nerve Stimulation
NCT03533140
Imaging With a Radio Tracer to Guide VT Ablations
NCT01250912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stellate ganglion block
All subjects will undergo stellate ganglion block during their VT ablation procedure
Stellate Ganglion Block
Left sided percutaneous stellate ganglion block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stellate Ganglion Block
Left sided percutaneous stellate ganglion block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age at least 18 years
Exclusion Criteria
* Contraindication to SGB or VT ablation
* Hypersensitivity of local anesthetic of amide type
* Hemodynamic instability during the procedure prior to the study protocol
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Timothy Markman, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
851066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.